Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Lipoprotein metabolism; Coronary artery disease; Pharmacotherapies;
مقالات ISI هیپرکلسترولمی فامیلی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: هیپرکلسترولمی فامیلی; ABCA1; ABCG1; Cholesterol efflux; Familial hypercholesterolemia; LDL apheresis; SR-BI;
Keywords: هیپرکلسترولمی فامیلی; PCSK9 inhibitors; Familial hypercholesterolemia; Cardiovascular events
Keywords: هیپرکلسترولمی فامیلی; Coronary artery disease; Familial hypercholesterolemia; High resolution melt analysis; LDLR; UK-Simon Broome criteria
Preliminary data of familial hypercholesterolemia (FH) patients in Romania
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Atherosclerosis; FHSC; Romania;
Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDL receptor; Lipoprotein apheresis; PCSK9; Xanthoma;
Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Prevalence; Sex; Race; Ethnicity; Epidemiology;
Ãvaluation des connaissances et pratiques sur le dépistage de l'hypercholestérolémie familiale hétérozygote chez l'enfant
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Screening of familial hypercholesterolemia; Dominant heterozygous familial hypercholesterolemia;
Variantes de un solo nucleótido asociadas con la hipercolesterolemia poligénica en familias diagnosticadas de hipercolesterolemia familiar
Keywords: هیپرکلسترولمی فامیلی; Hipercolesterolemia familiar; Variante de un solo nucleótido; Hipercolesterolemia poligénica; Familial hypercholesterolemia; Single nucleotide variants; Polygenic hypercholesterolemia; cLDL; colesterol unido a lipoproteÃnas de baja densidad; HF; hiperc
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Lipoprotein(a); Proprotein convertase subtilisin/kexin type 9; Familial hypercholesterolemia; Lipoprotein subfractions;
Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Low-density lipoprotein receptor gene; Colombia; Cardiovascular risk;
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Dutch Lipid Clinic Network score; Genetic testing;
What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Turkey; Registry;
Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Registry; Greece; Hellenic Familial Hypercholesterolemia Registry; Cardiovascular disease; Hypolipidemic treatment;
The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Statin; LDL cholesterol; New onset ASCVD;
Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes
Keywords: هیپرکلسترولمی فامیلی; ABC; ATP binding cassette; CD36; cluster of differentiation 36; CHOP; CEBP homologous protein; CVD; cardiovascular disease; DBP; diastolic blood pressure; DiI; 1,1â²-dioctadecyl-3,3,3â²,3â²-tetramethyl indocarbocyanine percholate; ER; endoplasmic retic
PCSK9 inhibitors in clinical practice: Delivering on the promise?
Keywords: هیپرکلسترولمی فامیلی; PCSK9 inhibitors; Familial hypercholesterolemia; Statin intolerance; Hypercholesterolemia; Lipid-lowering drugs;
Pediatric reference intervals for calculated LDL cholesterol, non-HDL cholesterol, and remnant cholesterol in the healthy CALIPER cohort
Keywords: هیپرکلسترولمی فامیلی; Reference intervals; Pediatric; CALIPER; Non-fasting lipids; LDL cholesterol; Non-HDL cholesterol; Remnant cholesterol; apoA1; apolipoprotein A1; apoB; apolipoprotein B; BMI; body mas index; CALIPER; Canadian Laboratory Initiative on Pediatric Reference I
The development of the Mexican Familial Hypercholesterolemia (FH) National Registry
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Mexico; Registry;
Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Achilles tendon thickness; Acute coronary syndrome; Coronary artery disease; Low-density lipoprotein;
Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDL-C goal attainment; Treatment pattern; LDL-Cholesterol; Statins; Ezetimibe;
DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Familial-defective apolipoprotein B-100; Low-density lipoprotein-receptor; Apolipoprotein B-100; LDLR; APOB; Pathogenic variants; Prevalence; Genotype; Phenotype; Phenotypic characteristics; Diagnostic value; Dutch Lipid Cli
PCSK9 inhibition in the management of familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; PCSK9; Familial hypercholesterolemia; Therapeutic target; Lipoprotein apheresis;
Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDL-C SNP-Score; Polygenic hyper-cholesterolemia; Variants of unknown significance (VUS);
Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Next generation sequencing; Mutation spectrum; LDLR; Haplotype; Structural variation;
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Children; IDOL; LDLR; PCSK9; LDL; 2D-1H-NMR; Lp(a); Triglyceride;
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Children; LDL cholesterol; Lipid-lowering therapy; Genetic testing;
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; ABO; Blood group; Cardiovascular disease; Familial hypercholesterolemia; Total cholesterol;
Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; APOB variants; Functional studies;
Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDLR; LDLRAP1; Xanthomata; Next-generation sequencing; Missense variant; Coronary heart diseases;
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDL-C goal attainment; PCSK9 inhibitor; CaRe High registry;
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study
Keywords: هیپرکلسترولمی فامیلی; PCSK9; LDL-C; Familial hypercholesterolemia; Evolocumab; Monoclonal antibody; Safety;
First case of sitosterolemia caused by double heterozygous mutations in ABCG5 and ABCG8 genes
Keywords: هیپرکلسترولمی فامیلی; Sitosterolemia; ABCG5; ABCG8; Familial hypercholesterolemia;
A Clinical Decision Support Tool for Familial Hypercholesterolemia Based on Physician Input
Keywords: هیپرکلسترولمی فامیلی; CDS; clinical decision support; CHD; coronary heart disease; EHR; electronic health record; FH; familial hypercholesterolemia; LDL-C; low-density lipoprotein cholesterol;
Sex differences in cholesterol levels from birth to 19Â years of age may lead to increased cholesterol burden in females with FH
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Children; Sex; Age; Cholesterol;
Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: AÂ model that explores the efficacy of conventional and novel lipid-lowering therapy
Keywords: هیپرکلسترولمی فامیلی; CETP inhibitor; Familial hypercholesterolemia; LDL-Cholesterol; PCSK9 inhibitor; Statin therapy;
LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis
Keywords: هیپرکلسترولمی فامیلی; LDL receptor; Golden Syrian hamster; Hyperlipidemia; Atherosclerosis; CRISPR/Cas9; ApoB; apolipoprotein B; ApoE; Apolipoprotein E; CETP; cholesteryl ester transfer protein; CAD; coronary artery disease; CD; chow diet; CHD; cardiovascular heart diseases; C
Role of sEH R287Q in LDLR expression, LDL binding to LDLR and LDL internalization in BEL-7402 cells
Keywords: هیپرکلسترولمی فامیلی; FH; familial hypercholesterolemia; LDL-C; low-density lipoprotein cholesterol; sEH; soluble epoxide hydrolase; EPHX2; epoxide hydrolase 2; CLSM; Confocal Laser Scanning Microscope; Familial hypercholesterolemia (FH); Epoxide hydrolase (sEH) R287Q; Hydrola
Lipoprotein-associated phospholipase Aâ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Lipoprotein-associated phospholipase A2; Familial hypercholesterolemia; Cardiovascular disease; Plaque vulnerability; Vascular inflammation; Cardiovascular risk; Statin treatment; Low density lipoprotein;
Clinical Genetic Testing for Familial Hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; cascade testing; consensus statement; familial hypercholesterolemia; genetic counseling; genetic testing; ACMG; American College of Medical Genetics and Genomics; APOB; apolipoprotein B; CAD; coronary artery disease; DLCNC; Dutch Lipid Clinic Network Diag
Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; LDL-cholesterol; HDL-cholesterol; Coronary heart disease; Cardiovascular disease; Coagulation;
Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A caseâcontrol study
Keywords: هیپرکلسترولمی فامیلی; FH; familial hypercholesterolemia; LDLR; low-density lipoprotein receptor; APOB; apolipoprotein B; PCSK9; proprotein convertase subtilisin/kexin type 9; LDL-C; low-density lipoprotein cholesterol; Lp(a); lipoprotein (a); ASCVD; atherosclerotic cardiovascu
Screening of LDLR and APOB gene mutations in Mexican patients with homozygous familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Homozygote state; LDLR mutations; Novel mutation c.-139delCTCCCCCTGC;
Effect of short-term hazelnut consumption on DNA damage and oxidized LDL in children and adolescents with primary hyperlipidemia: a randomized controlled trial
Keywords: هیپرکلسترولمی فامیلی; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; FCHL; familial combined hyperlipidemia; FH; familial hypercholesterolemia; FPG; formamidopyrimidine DNA glycosylase; HDL-C; high-density lipoprotein cholesterol; HZN+S; hazelnuts
Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; PCSK9 inhibition; Event reduction;
Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Children FH; Opportunistic screening; Reverse cascade screening; Direct cascade screening;
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Coronary CTA; Coronary artery disease; Prognosis;
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
Keywords: هیپرکلسترولمی فامیلی; PHACTR1; Coronary artery disease; Familial hypercholesterolemia; Cardiovascular disease; Risk stratification;
PCSK9 inhibitor therapy in homozygous familial defective apolipoprotein B-100 due to APOB R3500Q: A case report
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Familial defective apolipoprotein B-100; PCSK9 inhibitor;
LDL apheresis in Japan
Keywords: هیپرکلسترولمی فامیلی; Familial hypercholesterolemia; Atherosclerosis; Peripheral artery disease;